More than two-thirds of Asian patients with ischaemic diabetic heel ulcers survived without requiring an amputation at 1 year following lower limb revascularization surgery — a rate better than previously reported in the literature, according to a local study.
Patients with multivessel coronary artery disease (CAD) and diabetes treated with coronary artery bypass grafting (CABG) have improved long-term mortality and freedom from major cardiovascular and cerebrovascular events (MACCEs) compared to those treated with percutaneous coronary intervention (PCI), according to a study.
Metformin use in patients with type 2 diabetes (T2D) appears to contribute to an early reduction in haemoglobin levels, which in turn leads to a higher incidence of moderate anaemia, according to data from the MASTERMIND study.
Individuals with obesity are likely to maintain a healthy metabolic status on a vegetarian or vegan diet, according to a study. But simply adhering to this dietary pattern does not assure better outcome, because some plant-based foods are less nutritious.
In patients with type 1 diabetes (T1D) without known heart disease, cardiac time intervals positively correlate with major adverse cardiovascular events (MACE), according to a study presented at the ESC Congress 2020: The Digital Experience.
Patients with type 2 diabetes (T2D) who initiated SGLT2* inhibitors (SGLT2is) had better cardiovascular (CV) outcomes than those on DPP-4** inhibitors, shows the large, global, real-world study, CVD-REAL 2.
In the treatment of patients with type 2 diabetes (T2D) and nonalcoholic fatty liver disease (NAFLD), the first-in-class GLP-1/glucagon dual-receptor agonist cotadutide confers positive effects on body weight, alanine aminotransferase levels, and markers of liver fat and fibrosis, although these benefits appear to come with adverse gastrointestinal events, as shown in a phase IIb study.
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa,
08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.